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MRIAbstract Complete androgen insensitivity syndrome is an X-linked recessive androgen receptor
disorder. It is characterized by female phenotype with XY karyotype. Patients have normal female
external genitalia and absent Mullerian duct derivatives with the presence of testes. It occurs in up
to 5 every 100,000 males. Imaging is important to diagnose and to localize gonads prior to surgical
treatment. We report a case of 20-year-old female who presented with primary amenorrhea to our
department. Investigations revealed the absence of female internal genitalia and the presence of
testes on MRI in the inguinal canal under the skin. Gonadectomy was done and she was put on
female hormone replacement therapy.
 2016 The Egyptian Society of Radiology andNuclearMedicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Androgen insensitivity syndrome (AIS) was first described by
Morris (1), as an inherited X-linked recessive disorder where
there is inability of the end organs to respond to androgens
due to lack or defect of androgen receptor. They are males
(XY) on genetic basis but phenotypically and psychologically
females (2) usually present with primary amenorrhea or infer-
tility with feminine breast, but sparse axillary and pubic hair,
normal external genitalia and short and blind vagina. The
upper two-thirds of vagina, uterus and tubes are absent. Gon-
ads (testes) are positioned in the labia, inguinal canal or intra-abdominal (2). Because of rarity, we present this case of AIS,
in which the testes were identified by MRI.
2. Case report
A 20-year-old female was referred to our hospital with primary
amenorrhea, single virgin female. There was history of prior
medical consultation for the same cause with no diagnosis.
On examination her vitals were stable, height 175 cm, weight
75 kg. Secondary sexual characters are as follows: the breasts
were underdeveloped, and axillary and pubic hair were sparse.
She had a male karyotype but normal female external genitalia
and a blind-pouch vagina. She was referred to our department
for further evaluation. Laboratory investigations revealed the
following: serum FSH= 62 IU/L, LH= 36 IU/L, estra-
diol = 15 pg/ml and testosterone = 3.6 ng/dl. Ultrasound
revealed the absent female internal genitalia. The MRI exam
(Fig. 1) confirmed the absence of feminine internal genitalia
with oval hyper-dense structure solid structures distal to the
Fig. 1 MRI showing right and left testes in the subcutaneous tissues of the groin.
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dimensions which is features of undescended testes with both
normal kidneys. Bilateral gonadectomy was done by urology
surgeon, and then the patient was planned for hormonal sub-
stitution with estrogens.
3. Discussion
This disorder is characterized by gene at the proximal long arm
of the X chromosome at Xq11-12 (1,2). The type of mutation
present will differentiate it. It can be complete (CAIS), partial
(PAIS), or mild (MAIS). Testes produce testosterone but they
do not develop male genitalia or male secondary sexual char-
acters. The Sertoli cells produce Mullerian-inhibiting factor
(MIF) so, they do not develop Mullerian derivatives (3,4). In
complete type, there is male karyotype with a female pheno-
type and female gender identity with normal breast, little pubic
and axillary hair, primary amenorrhea, and a blind-pouch
vagina (5). Patients sometimes require vaginal dilatation or
surgical reconstruction. They are usually taller than normal
women but shorter than males (6). They have low bone min-
eral density before and after gonadectomy (7) so, it should
be corrected by estrogen replacement therapy and/or calcium
and vitamin D supplements. Their serum testosterone levels
are in the normal range for males, and estradiol levels are
higher than males but lower than females (8,9). Karyotyping
should be considered in all female infants diagnosed with a
bilateral inguinal hernia at birth (10) because it is rare in nor-
mal female infants and associated with CAIS in 1–2% of cases
(11). An abdominal testes may undergo malignant degenera-
tion, but since the testes are normal and not dysgenetic in
CAIS, prepubertal tumors are rare about 0.8% (12), whereas
in adults the risk is 14% (13). So, it is important to perform
gonadectomy soon after puberty (14). In case of suspected
malignant transformation before puberty, the testes should
be removed and puberty is induced with estrogen replacement(15). A very common differential diagnosis of CAIS is the
Mayer–Rokitansky–Kuster–Hauser (MRKH) syndrome.
Patients in the latter syndrome have a female karyotype and
female external genitalia and ovaries with aplasia of the uterus
and the upper part of the vagina (16).
Ultrasound assesses the absence of Mullerian structures
and can locate the testes. Since ultrasound is operator depen-
dent and can be inconclusive (17), MRI is the study of choice,
with accuracy 100% for evaluation of Mullerian anomalies
and testes position (18). Sagittal and transverse T2-weighted
images and T1-weighted images are used to assess the absence
of the uterus, vagina, the presence and location of the testes
and testicular malignancy (19,20). MRI is important to plan
gonadectomy and is used with tumor markers, for patients
who refuse surgical removal of the testes in follow-up (19).
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